ResMed | RMD - Loan Capital

Stock Price
271.71
Daily Change
4.66 1.74%
Monthly
9.47%
Yearly
14.67%
Q1 Forecast
250.35

ResMed reported $403.92M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Ansell USD 638.5M 68.1M Jun/2025
AtriCure USD 61.86M 0 Sep/2025
Baxter International USD 9.49B 80M Jun/2025
Cochlear AUD 193.5M 10M Jun/2025
Cooper Companies USD 2.46B 26.1M Sep/2025
CSL USD 10.69B 1.37B Jun/2025
Dexcom USD 1.29B 55.6M Sep/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Fisher Paykel Healthcare NZD 62.6M 4.3M Dec/2025
Globus Medical USD 173K 84K Jun/2025
Haemonetics USD 919.99M 406K Dec/2025
Hologic USD 2.5B 2.1M Dec/2025
Idexx Laboratories USD 374.82M 74.99M Sep/2025
Insulet USD 934.9M 4.1M Sep/2025
Integra LifeSciences USD 1.79B 565.41M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 559.1M 39.6M Sep/2025
Medtronic USD 26.18B 537M Jun/2025
Philips EUR 7.24B 55M Sep/2025
Ramsay Health Care AUD 5.46B 5.23B Jun/2025
ResMed USD 403.92M 4.74M Dec/2025
Sigma Healthcare AUD 1.88B 1.75B Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Steris USD 1.9B 1.1M Dec/2025
Teleflex USD 2.57B 769.86M Sep/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025